PCMI
LAB icon

Paradigm Capital Management Inc’s Standard BioTools LAB Stock Holding History

Paradigm Capital Management Inc’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,457
Closed -$20.9K – 129
2025
Q2 		$20.9K Sell
17,457
-230,943
-93% -$256K ﹤0.01% 122
2025
Q1 		$268K Hold
248,400
– – 0.01% 121
2024
Q4 		$435K Sell
248,400
-301,600
-55% -$562K 0.02% 113
2024
Q3 		$1.06M Hold
550,000
– – 0.05% 96
2024
Q2 		$974K Hold
550,000
– – 0.04% 98
2024
Q1 		$1.49M Buy
550,000
+500,000
+1,000% +$1.21M 0.07% 87
2023
Q4 		$111K Buy
+50,000
New +$107K 0.01% 130
2022
Q1 		– Sell
-771,100
Closed -$3.02M – 155
2021
Q4 		$3.02M Sell
771,100
-144,900
-16% -$678K 0.14% 92
2021
Q3 		$6.04M Hold
916,000
– – 0.31% 74
2021
Q2 		$5.64M Sell
916,000
-329,000
-26% -$1.76M 0.27% 76
2021
Q1 		$5.63M Sell
1,245,000
-281,100
-18% -$1.54M 0.29% 71
2020
Q4 		$9.16M Buy
1,526,100
+542,000
+55% +$3.56M 0.55% 47
2020
Q3 		$7.31M Sell
984,100
-521,600
-35% -$3.6M 0.61% 52
2020
Q2 		$6.04M Buy
1,505,700
+18,000
+1% +$62.7K 0.55% 50
2020
Q1 		$3.78M Buy
1,487,700
+809,800
+119% +$2.66M 0.46% 56
2019
Q4 		$2.36M Buy
677,900
+552,700
+441% +$1.94M 0.18% 86
2019
Q3 		$580K Buy
+125,200
New +$986K 0.05% 125

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Paradigm Capital Management Inc's LAB Position: Q3 2025 in Review

Paradigm Capital Management Inc sold out of Standard BioTools (LAB) in Q3 2025, closing a stake of 17,457 shares — an estimated $20.9K sold.

Paradigm Capital Management Inc first reported a position in LAB in Q3 2019 and held it in 17 quarters. The position peaked at $9.16M in Q4 2020. 155 funds tracked by Wall St. Rank hold LAB as of Q3 2025.

  • Paradigm Capital Management Inc reported no remaining Standard BioTools position as of Q3 2025 after selling out during the quarter.
  • Paradigm Capital Management Inc sold 17,457 Standard BioTools shares in Q3 2025, an estimated $20.9K.
  • Paradigm Capital Management Inc first reported a position in Standard BioTools in Q3 2019 and held it in 17 quarters.
  • Paradigm Capital Management Inc's Standard BioTools position peaked at $9.16M in Q4 2020.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2025.

Based on Paradigm Capital Management Inc's 13F filing for Q3 2025, filed 14 Nov 2025.